查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗生素抗药性市场，按疾病类型、病原体类型、药物类别、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1358223

抗生素抗药性市场，按疾病类型、病原体类型、药物类别、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Antibiotic Resistance Market, By Disease Type, By Pathogen Type, By Drug Class, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年抗生素抗药性市场规模为 80.057 亿美元，2023 年至 2030 年复合年增长率为 6.1%。

抗生素抗药性市场 - 市场动态：

  • 增加细菌感染的流行以促进市场成长
  • 对传统抗生素产生抗药性的细菌性疾病的日益流行可能会增加对新疗法的需求，从而推动市场成长。随着抗生素抗药性的蔓延，对新抗生素的需求变得更加紧迫。这可能会导致製药公司增加研发投资。对细菌感染负担的全球综合估计已经发布。 2019年，全球有770万人死亡与细菌感染有关。这相当于全球死亡人数的八分之一。人工智慧和机器学习在药物研究中的整合为加速新型抗生素的创造提供了成长机会。然而，抗生素抗药性并未得到一般大众甚至医疗保健提供者的广泛认可。这可能导致不正确的处方和滥用。

抗生素抗药性市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，预计全球抗生素抗药性市场在预测期内（2023-2030 年）每年将以 6.1% 左右的复合年增长率增长
  • 根据疾病类型细分，预计泌尿道感染将在 2022 年显示最大的市场份额
  • 根据病原体类型细分，鲍曼不动桿菌是 2022 年的主导类型
  • 根据药物类别细分，噁唑烷酮类药物是 2022 年的主导类型
  • 根据最终用户细分，医院是 2022 年的主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

抗生素抗药性市场-細項分析：

  • 全球抗生素抗药性市场根据疾病类型、病原体类型、药物类别、最终用户和地区进行细分。
  • 依疾病类型，市场分为四类：泌尿道感染、腹腔内感染、血流感染、艰难梭菌感染等。尿路感染主导市场成长。泌尿道感染是影响人类，尤其是女性最常见的细菌性疾病之一。尿路感染通常用抗生素治疗。然而，随着抗生素抗药性的日益普遍，管理和治疗泌尿道感染变得更加困难。
  • 依病原体类型，市场分为四大类：鲍曼不动桿菌、绿脓桿菌、金黄色葡萄球菌、肺炎链球菌等。鲍曼不动桿菌主导市场成长。鲍曼不动桿菌具有快速获得抗药性机制的固有倾向，使其成为医院环境中最麻烦的感染之一，特别是在重症监护病房 (ICU) 中。
  • 根据药物类别，市场分为三类：噁唑烷酮类、脂糖肽类、四环素类和其他。噁唑烷酮类产业在市场中占据主导地位，并可能在预测期内保持其主导地位。噁唑烷酮是用于治疗细菌感染的抗生素，特别是革兰氏阳性病原体引起的感染。利奈唑胺是最知名的噁唑烷酮。它们尤其重要，因为它们已被证明可有效对抗多重抗药性病原体，包括抗甲氧西林金黄色葡萄球菌（MRSA）和耐万古霉素肠球菌（VRE）。
  • 根据最终用户，市场分为三类：医院、家庭护理、专科诊所和其他。医院产业在市场上占据主导地位。医院对于抗生素抗药性的发展至关重要。它们既是抗药性细菌的滋生地，也是治疗超级细菌患者的主战场。面对抗生素抗药性的发展，医院的影响是复杂的，对医疗保健市场也产生了相当大的影响。

抗生素抗药性市场 - 地理洞察：

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。由于传染病的流行和医疗保健支出的增加，预计北美将主导市场的成长。北美，特别是美国，爆发了多种传染病，其中一些具有抗生素抗药性。例如，MRSA（耐甲氧西林金黄色葡萄球菌）已成为美国许多医院和医疗机构的主要关注点。美国在人均医疗保健上的支出比世界上任何其他国家都多。据美国医学协会称，很大一部分收入用于研究、药物开发和诊断。 2021 年，美国医疗保健支出成长 2.7%，达到 4.3 兆美元，即人均 12,914 美元。这一增长率大幅低于 2020 年（10.3%）。由于对有效抗生素疗法的需求不断增长，预计欧洲和亚太地区对双特异性抗药性市场的需求将会增加。

抗生素抗药性市场-竞争格局：

抗生素抗药性已成为全球关注的主要议题。随着细菌进化并对现有药物产生抗药性，感染的治疗变得更加困难，导致病程更长、住院次数增加以及死亡率上升。生产商一直积极进行抗生素研究，但迫于经济压力，一些大型製药公司减少或停止了抗生素研究计画。辉瑞、默克、葛兰素史克和罗氏代表了一些涉足製药业的公司。全面的竞争性研究必须考虑製药公司、诊断公司、研究机构和替代治疗方式。例如，2021 年5 月，巴塞利亚製药有限公司（Basilea Pharmaceutical Ltd.，股票代码：BSLN）今天宣布，它已获得CARB-X（抗击抗生素抗药性细菌生物製药加速器）高达270 万美元的资助， CARB-X 是一家全球合作伙伴，致力于支持抗菌产品的早期开发，以诊断、预防和治疗抗药性感染。

最近的发展：

2020 年 11 月 18 日，默克（在美国和加拿大以外地区称为 MSD）最近宣布推出全球抗菌素抗药性趋势监测研究 (SMART) 新网站。 SMART 于 2002 年启动，是世界上规模最大、运行时间最长的抗菌素抗药性 (AMR) 监测研究之一，涵盖 60 多个国家的 200 多个地点。

目录

第一章：抗生素抗药性市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按疾病类型分類的抗生素抗药性市场片段
    • 按病原体类型分類的抗生素抗药性市场片段
    • 按药物类别分類的抗生素抗药性市场片段
    • 最终用户的抗生素抗药性市场片段
    • 按国家/地区分類的抗生素抗药性市场片段
    • 按地区分類的抗生素抗药性市场片段
  • 竞争洞察

第 3 章：抗生素抗药性主要市场趋势

  • 抗生素抗药性市场驱动因素
    • 市场驱动因素的影响分析
  • 抗生素抗药性市场限制
    • 市场限制影响分析
  • 抗生素抗药性市场机会
  • 抗生素抗药性市场未来趋势

第 4 章：抗生素抗药性产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：抗生素抗药性市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：抗生素抗药性市场格局

  • 2022 年抗生素抗药性市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：抗生素抗药性市场 - 依疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 泌尿道感染
    • 腹腔内感染
    • 血流感染
    • 艰难梭菌感染
    • 其他的

第 8 章：抗生素抗药性市场 - 依病原体类型

  • 概述
    • 按病原体类型分類的细分市场份额分析
    • 鲍曼不动桿菌
    • 铜绿假单胞菌
    • 金黄色葡萄球菌
    • 肺炎链球菌
    • 其他的

第 9 章：抗生素抗药性市场 - 按药物类别

  • 概述
    • 按药物类别分類的细分市场份额分析
    • 噁唑烷酮类
    • 脂糖肽
    • 四环素类
    • 其他的

第 10 章：抗生素抗药性市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 居家护理
    • 专科诊所
    • 其他的

第 11 章：抗生素抗药性市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美抗生素抗药性主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按病原体类型）
    • 北美市场规模和预测（按药物类别）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲抗生素抗药性主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按病原体类型）
    • 欧洲市场规模和预测（按药物类别）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区抗生素抗药性主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模和预测（按病原体类型）
    • 亚太地区市场规模和预测（按药物类别）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲抗生素抗药性主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模和预测（按病原体类型）
    • 拉丁美洲市场规模与预测（按药物类别）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲抗生素抗药性主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模及预测（按病原体类型）
    • 中东和非洲市场规模及预测（按药物类别）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 抗生素抗药性产业

  • 竞争仪表板
  • 公司简介
    • Achaogen Inc
    • Nabriva Therapeutics plc
    • BioVersys AG
    • Johnson & Johnson Services, Inc.
    • Destiny Pharma plc
    • Armata Pharmaceuticals, Inc.
    • West Way Health
    • The Medicines Company
    • Merck & Co., Inc.
    • Pfizer Inc.
    • CARB-X
    • Melinta Therapeutics LLC
    • Novartis AG
    • Vertex Pharmaceuticals Incorporated
    • GSK plc.
    • AbbVie Inc.
    • F. Hoffmann-La Roche Ltd

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1722

REPORT HIGHLIGHT

Antibiotic Resistance Market size was valued at USD 8,005.7 million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.

Antibiotic resistance emerges when bacteria adapt to the usage of these medications. It develops in bacteria instead of people or animals. These bacteria can infect humans and animals, and their infections are more difficult to treat than infections caused by non-resistant bacteria. Antibiotic resistance is accelerated by antibiotic abuse and overuse, as well as inadequate infection prevention and control. At all levels of society, steps can be made to decrease the impact and spread of resistance. Antibiotic resistance is a global issue and requires cooperation between nations, industries, and organizations. Investing in the development of new antibiotics, as well as alternative therapies like bacteriophages and antimicrobial peptides. For example, Methicillin-Resistant Staphylococcus Aureus (MRSA's) emergence and spread show the quick rate at which germs can adapt to drugs, as well as the continual problem that healthcare personnel face in treating bacterial illnesses. It emphasizes the critical need for effective antibiotic usage, improved infection control procedures, and the discovery of novel antibiotics.

Antibiotic Resistance Market - Market Dynamics:

  • Increasing the prevalence of bacterial infection to increase market growth
  • The increasing prevalence of bacterial illnesses resistant to conventional antibiotics may increase demand for novel remedies, driving market growth. As antibiotic resistance spreads, the need for new antibiotics becomes more pressing. This could lead to increased investment in R&D by pharmaceutical corporations. Global comprehensive estimates of the burden of bacterial infections have been published. In 2019, 7.7 million deaths around the world were found to be linked to bacterial infections. That equals 1 in 8 of all global deaths. The integration of AI and machine learning in drug research provides a growth opportunity to accelerate the creation of novel antibiotics. However, Antibiotic resistance is not widely recognized by the general population and even by healthcare providers. This can lead to incorrect prescribing and abuse.

Antibiotic Resistance Market - Key Insights:

  • As per the analysis shared by our research analyst, the global Antibiotic Resistance market is estimated to grow annually at a CAGR of around 6.1% over the forecast period (2023-2030)
  • Based on Disease type segmentation, Urinary Tract Infections was predicted to show maximum market share in the year 2022
  • Based on Pathogen Type segmentation, Acinetobacter Baumannii was the leading type in 2022
  • Based on Drug class segmentation, Oxazolidinones were the leading type in 2022
  • Based on End-User segmentation, Hospitals was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Antibiotic Resistance Market- Segmentation Analysis:

  • The Global Antibiotic Resistance Market is segmented on the basis of Disease type, Pathogen Type, Drug class, End-User, and Region.
  • The market is divided into four categories based on Disease type: Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, and Others. Urinary Tract Infections dominate the market growth. UTIs are one of the most common bacterial diseases that affect humans, particularly women. UTIs are often treated with antibiotics. However, with the increasing prevalence of antibiotic resistance, managing and treating UTIs is becoming more difficult.
  • The market is divided into four categories based on Pathogen Type: Acinetobacter Baumannii, Pseudomonas Aeruginosa, Staphylococcus Aureus, Streptococcus pneumonia, and Others. Acinetobacter Baumannii dominates the market growth. A. baumannii has an inherent propensity to rapidly acquire resistance mechanisms, making it one of the most troublesome infections in hospital settings, particularly in intensive care units (ICUs).
  • The market is divided into three categories based on Drug class: Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others. The Oxazolidinones sector dominates the market and is likely to maintain its dominance during the forecast period. Oxazolidinones are antibiotics that are used to treat bacterial infections, particularly those caused by Gram-positive pathogens. Linezolid is the most well-known oxazolidinone. They are especially significant since they have been shown to be effective against multi-drug resistance pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
  • The market is divided into three categories based on End-User: Hospitals, Homecare, Specialty Clinics, and Others. The hospital sector dominates the market. Hospitals are essential to the development of antibiotic resistance. They are both a breeding ground for resistant bacteria and a main battleground for treating people sick with these superbugs. The implications for hospitals in the face of developing antibiotic resistance are complex, with considerable ramifications for the healthcare market.

Antibiotic Resistance Market - Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to the increasing prevalence of infectious diseases and rising healthcare expenditure. North America, especially the United States, has had outbreaks of many infectious diseases, some of which are antibiotic-resistant. MRSA (Methicillin-resistant Staphylococcus aureus), for example, has become a major concern in many U.S. hospitals and healthcare settings. The United States spends more on healthcare per capita than any other country in the world. According to the American Medical Association, a significant amount of the revenue is spent on research, drug development, and diagnostics. Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD 12,914 per capita. This growth rate is substantially lower than in 2020 (10.3% percent). Europe and Asia Pacific are projected to demand for Bispecific Resistance Market, due to the growing demand for effective antibiotic therapies.

Antibiotic Resistance Market- Competitive Landscape:

Antibiotic resistance has emerged as a major global concern. As bacteria evolve and become resistant to existing medicines, infections become more challenging to treat, leading to longer illnesses, more hospitalizations, and a rise in mortality. The manufacturers have been active in antibiotic research, however owing to economic pressures, some large pharmaceutical corporations have reduced or discontinued their antibiotic research projects. Pfizer, Merck, GlaxoSmithKline, and Roche represent some of the companies involved in the pharmaceutical industry. A comprehensive competitive study must consider pharmaceutical businesses, diagnostic companies, research institutes, and alternative treatment modalities. For instance, On May 2021, Basilea Pharmaceutical Ltd. (SIX: BSLN) announced today that it has been awarded a grant of up to USD 2.7 million from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), a global partnership dedicated to supporting the early development of antibacterial products to diagnose, prevent and treat drug-resistant infections.

Recent Developments:

November 18, 2020, Merck, known as MSD outside the United States and Canada, recently, announced the launch of a new website for the global Study for Monitoring Antimicrobial Resistance Trends (SMART). SMART, which was initiated in 2002, is one of the world's largest and longest-running antimicrobial resistance (AMR) surveillance studies including more than 200 sites across more than 60 countries.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIBIOTIC RESISTANCE MARKET KEY PLAYERS

  • Achaogen Inc
  • Nabriva Therapeutics plc
  • BioVersys AG
  • Johnson & Johnson Services, Inc.
  • Destiny Pharma plc
  • Armata Pharmaceuticals, Inc.
  • West Way Health
  • The Medicines Company
  • Merck & Co., Inc.
  • Pfizer Inc.
  • CARB-X
  • Melinta Therapeutics LLC
  • Novartis AG
  • Vertex Pharmaceuticals Incorporated
  • GSK plc.
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd

GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY DISEASE TYPE

  • Urinary Tract Infection
  • Intra-Abdominal Infections
  • Blood Stream Infections
  • Clostridium Difficile Infections
  • Others

GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY PATHOGEN TYPE

  • Acinetobacter Baumannii
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Streptococcus pneumoniae
  • Others

GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY DRUG CLASS

  • Oxazolidinones
  • Lipoglycopeptides
  • Tetracyclines
  • Others

GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY END-USER

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antibiotic Resistance Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antibiotic Resistance Market Snippet by Disease Type
    • 2.1.2. Antibiotic Resistance Market Snippet by Pathogen Type
    • 2.1.3. Antibiotic Resistance Market Snippet by Drug Class
    • 2.1.4. Antibiotic Resistance Market Snippet by End-User
    • 2.1.5. Antibiotic Resistance Market Snippet by Country
    • 2.1.6. Antibiotic Resistance Market Snippet by Region
  • 2.2. Competitive Insights

3. Antibiotic Resistance Key Market Trends

  • 3.1. Antibiotic Resistance Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antibiotic Resistance Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antibiotic Resistance Market Opportunities
  • 3.4. Antibiotic Resistance Market Future Trends

4. Antibiotic Resistance Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antibiotic Resistance Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Antibiotic Resistance Market Landscape

  • 6.1. Antibiotic Resistance Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antibiotic Resistance Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 7.1.2. Urinary Tract Infection
    • 7.1.3. Intra-Abdominal Infections
    • 7.1.4. Blood Stream Infections
    • 7.1.5. Clostridium Difficile Infections
    • 7.1.6. Others

8. Antibiotic Resistance Market - By Pathogen Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Pathogen Type, 2022 & 2030 (%)
    • 8.1.2. Acinetobacter Baumannii
    • 8.1.3. Pseudomonas Aeruginosa
    • 8.1.4. Staphylococcus Aureus
    • 8.1.5. Streptococcus pneumoniae
    • 8.1.6. Others

9. Antibiotic Resistance Market - By Drug Class

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 9.1.2. Oxazolidinones
    • 9.1.3. Lipoglycopeptides
    • 9.1.4. Tetracyclines
    • 9.1.5. Others

10. Antibiotic Resistance Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Homecare
    • 10.1.4. Specialty Clinics
    • 10.1.5. Others

11. Antibiotic Resistance Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Antibiotic Resistance Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Antibiotic Resistance Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Antibiotic Resistance Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Antibiotic Resistance Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Antibiotic Resistance Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Antibiotic Resistance Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Achaogen Inc
    • 12.2.2. Nabriva Therapeutics plc
    • 12.2.3. BioVersys AG
    • 12.2.4. Johnson & Johnson Services, Inc.
    • 12.2.5. Destiny Pharma plc
    • 12.2.6. Armata Pharmaceuticals, Inc.
    • 12.2.7. West Way Health
    • 12.2.8. The Medicines Company
    • 12.2.9. Merck & Co., Inc.
    • 12.2.10. Pfizer Inc.
    • 12.2.11. CARB-X
    • 12.2.12. Melinta Therapeutics LLC
    • 12.2.13. Novartis AG
    • 12.2.14. Vertex Pharmaceuticals Incorporated
    • 12.2.15. GSK plc.
    • 12.2.16. AbbVie Inc.
    • 12.2.17. F. Hoffmann-La Roche Ltd

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Antibiotic Resistance Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Antibiotic Resistance Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Antibiotic Resistance Market: Pathogen Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Pathogen Type
  • TABLE Global Antibiotic Resistance Market, by Pathogen Type 2018-2030 (USD Million)
  • TABLE Antibiotic Resistance Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Antibiotic Resistance Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Antibiotic Resistance Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Antibiotic Resistance Market, by End-User 2018-2030 (USD Million)
  • TABLE Antibiotic Resistance Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Antibiotic Resistance Market, by Region 2018-2030 (USD Million)
  • TABLE North America Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE North America Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
  • TABLE North America Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
  • TABLE Europe Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
  • TABLE Latin America Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Antibiotic Resistance Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Disease Type segment market share analysis, 2022 & 2030
  • FIGURE Disease Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Pathogen Type segment market share analysis, 2022 & 2030
  • FIGURE Pathogen Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Drug Class segment market share analysis, 2022 & 2030
  • FIGURE Drug Class segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Antibiotic Resistance Market share and leading players, 2022
  • FIGURE Europe Antibiotic Resistance Market share and leading players, 2022
  • FIGURE Asia Pacific Antibiotic Resistance Market share and leading players, 2022
  • FIGURE Latin America Antibiotic Resistance Market share and leading players, 2022
  • FIGURE Middle East and Africa Antibiotic Resistance Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Antibiotic Resistance Market share analysis by country, 2022
  • FIGURE Germany Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Antibiotic Resistance Market share analysis by country, 2022
  • FIGURE India Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antibiotic Resistance Market share analysis by country, 2022
  • FIGURE Brazil Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antibiotic Resistance Market share analysis by country, 2022
  • FIGURE Saudi Arabia Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Antibiotic Resistance Market size, forecast and trend analysis, 2018 to 2030 (USD Million)